{
    "clinical_study": {
        "@rank": "13372", 
        "arm_group": {
            "arm_group_label": "LV-EF > 50%", 
            "arm_group_type": "Experimental", 
            "description": "PiCCO catheter analysis of patients with coronary heart disease without impaired left ventricular function [LV-EF > 50%]"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine the validation of the PiCCO (Pulse Contour Cardiac\n      Output)-derived transpulmonary thermodilution technology in patients with heart diseases."
        }, 
        "brief_title": "Transpulmonary Thermodilution Measurements in Patients With Heart Diseases", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Diseases", 
        "condition_browse": {
            "mesh_term": "Heart Diseases"
        }, 
        "detailed_description": {
            "textblock": "-  How do PiCCO and PAC (pulmonary artery catheter) derived hemodynamic variables change\n           in different cardiac pathologies?\n\n        -  How do PiCCO hemodynamic variables compare to transthoracic echocardiographic\n           parameters in different cardiac pathologies?\n\n        -  How does GEDV (global enddiastolic volume) correlate with left ventricles end-diastolic\n           volume (LVEDV) assessed by LV (left ventricle) ventriculography and echocardiography?\n\n        -  How do PiCCO cardiac function variables (GEF [global ejection fraction]; CFI [cardiac\n           function index]) correlate with LV dP/dt max, LVEF (left ventricular ejection fraction)\n           assessed by LV ventriculography and echocardiography, LVFAC (left ventricular\n           fractional area of change), LV stroke work index (LVSWI) and cardiac power (CP)?\n\n        -  How does GEDV compare to LVEDV and left ventricular end-diastolic pressure (LVEDP) as\n           assessed by the pulmonary artery occlusion pressure (PAOP)?\n\n        -  How does right ventricular function influence GEDV, GEF and CFI?"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Coronary heart disease without impaired left ventricular function [LV-EF > 50%]\n             (n=10, control group)\n\n          -  Coronary heart disease with impaired left ventricular function [LV-EF < 50%] (n=10)\n\n          -  Dilated cardiomyopathy (n=10),\n\n          -  Aortic valve stenosis (n=10),\n\n          -  Mitral valve regurgitation (n=10),\n\n          -  Diastolic left ventricular dysfunction (n=10) and\n\n          -  Right heart failure (n=10)\n\n        Exclusion criteria:\n\n          -  Patients with catecholamine dependent cardiogenic shock, severe respiratory distress\n             because of pulmonary oedema, intubated patients, patients with atrial fibrillation,\n             atrioventricular conduction abnormalities, and slow ventricular tachycardia will not\n             be included.\n\n          -  Moreover patients not being able to give informed consent are excluded. Even more,\n             pregnant women are excluded from the study due to the radiation exposure in line with\n             heart catheterization. A pregnancy test will be performed prior to participating with\n             this study.\n\n          -  The age does not represent an exclusion criterion."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 2, 2009", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02035007", 
            "org_study_id": "Version 2, 17.04.09 / EK1649"
        }, 
        "intervention": {
            "arm_group_label": "LV-EF > 50%", 
            "description": "Measuring of PiCCO derived values", 
            "intervention_name": "PiCCO Catheter (Pulsiocath 5F)", 
            "intervention_type": "Device", 
            "other_name": "Pulsiocath 5F, Pulsion Medical Systems, Munich, Germany"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 10, 2014", 
        "location": {
            "contact": {
                "email": "daniel.franzen@usz.ch", 
                "last_name": "Daniel Franzen, MD", 
                "phone": "++411442551111"
            }, 
            "contact_backup": {
                "email": "marco.maggiorini@usz.ch", 
                "last_name": "Marco Maggiorini, Prof.", 
                "phone": "++411442551111"
            }, 
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "zip": "8091"
                }, 
                "name": "Medical Intensive Care Unit, University Hospital of Zurich"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Transpulmonary Thermodilution Measurements in Patients With Heart Diseases", 
        "overall_contact": {
            "last_name": "01 Studienregister MasterAdmins", 
            "phone": "+41 (0)44 255 11 11"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Medical Intensive Care Unit", 
            "last_name": "Marco Maggiorini, Prof MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Outcome measure is obtained during PiCCO measurement and left/right heart catherization, respectively (\"point-of-care\" measurement). There is no follow-up examination thereafter.", 
            "measure": "Cardiac Output, Preload values (GEDV)", 
            "safety_issue": "No", 
            "time_frame": "Day 1 only"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02035007"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2009", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}